Categories: All postsMedia

Take a pass on DHX Media, this investor says

DHX Media
DHX Media (DHX Media Stock Quote, Chart TSX:DHX) has been through a turbulent stretch over the past couple of years, including last year which saw a management shakeup, a strategic review and drastic measures to reduce its debt load, all of which has reflected on the company’s dropping share price. Can this thing be turned around? The jury is still out, says Peter Hodson of 5i Research.

“This is a tough one. The company really screwed up badly and the stock went from close to ten dollars to around a dollar. Then it was put up for sale and nobody wanted to buy it, and so investors are saying, ‘Now, what do we do?’” says Hodson, founder and head of research at 5i Research, to BNN Bloomberg on Wednesday.

“They still have two real issues. One is execution on earnings: they have a very volatile earnings history, based on what’s going on at the time in the quarter. And two, they still have a pretty big debt level,” he says.

Last week, DHX reported its second quarter results for its fiscal 2019, featuring EBITDA of $22.0 million and revenue of $117.0 million, down from $121.9 million a year ago. Both its top and bottom lines came in moderately below the consensus estimates.

At the same time, the company’s internet-focused subsidiary WildBrain had its best quarter yet with revenue up 13 per cent to $19.9 million. Management also announced a company reorganization, effectively splitting DHX into two subsidiaries, one comprised of its production studios and TV business and the other made up of global distribution and merchandising.

“In our second quarter, we made progress against our three strategic priorities of producing premium content, growing WildBrain and improving cash generation,” said Michael Donovan, Executive Chair and CEO, in a press release. “We signed the largest content deal in the history of the Company, which we believe will contribute steady EBITDA for the coming years, and WildBrain continued to deliver double-digit growth. We also experienced a seven per cent rise in consumer products revenue from Peanuts. Our strategic shift and disciplined cost management contributed to positive cash flow and allowed us to pay down $9.5 million of our debt in the quarter.”

Hodson advises that investors stay on the sidelines for a while longer.

“We’d like to like this company a little bit more. They’ve got a very valuable library. There’s value there if they can make the deals. They just haven’t been able to make the deals as fast as investors were expecting,” he says.

“I’d give this one a couple more quarters. We really didn’t like it and now we’re just kind of neutral towards it,” he says.

Tagged with: dhx
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

MDA Space stock is a double from here, analyst says

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and street-high $88.00 target on MDA Space (MDA Space Stock Quote,… [Read More]

4 hours ago

Can Hammond Power stock go even higher?

National Bank Financial analyst Baltej Sidhu raised his target on Hammond Power Solutions (Hammond Power Solutions Stock Quote, Chart, News,… [Read More]

4 hours ago

What’s going on with Canada’s job losses?

RBC senior economist Claire Fan says Canada’s September job losses were concentrated among younger workers and should not be overread.… [Read More]

6 hours ago

This biotech stock has a massive upside, Roth says

Roth Capital Partners analyst Adam Walsh says a third controlled celiac disease dataset supporting IL-15 blockade increases the potential value… [Read More]

6 hours ago

Red-hot Firan Technology wins another price target raise

Beacon Securities analyst Russell Stanley raised his target on Firan Technology Group (Firan Technology Group Stock Quote, Chart, News, Analysts,… [Read More]

21 hours ago

Buy this Canadian pot stock, Research Capital says

Research Capital Corporation analyst Greg McLeish maintained his “Buy” rating and $3.50 target on Cannara Biotech (Cannara Biotech Stock Quote,… [Read More]

1 day ago